Policy Issues in the Development and Adoption of Biomarkers for Molecularly Targeted Cancer Therapies

Workshop Summary

AvInstitute of Medicine,Board on Health Care Services

Häftad, Engelska, 2015

Del i serien Clinical Trial Data Sharing

361 kr

Tillfälligt slut

Beskrivning

A long-held goal in oncology has been to develop therapies that target the specific abnormalities in each patient's cancer rather than simply treating cancers based on the tissue of origin. In the past decade, advances in technology have enabled researchers to relatively quickly and inexpensively determine, in minute detail, the genetic makeup of tumors. Although relatively few targeted cancer therapies are currently available in the clinic and it is not yet clear whether all cancers are driven by genetic changes that can be targeted, there is widespread optimism in the cancer community that this new ability to assess the genetic abnormalities in tumors will ultimately lead to better cancer treatments and improved patient outcomes. Policy Issues in the Development and Adoption of Biomarkers for Molecularly Targeted Cancer Therapies is the summary of a workshop convened in November 2014 by the Institute of Medicine's National Cancer Policy Forum to discuss recent trends in the development and implementation of molecularly targeted cancer therapies and explore potential policy actions to address specific challenges.This report highlights the presentations and discussions at the workshop.

Produktinformation

Utforska kategorier

Innehållsförteckning

Hoppa över listan

Mer från samma författare

Bereavement

Institute of Medicine, Committee for the Study of Health Consequences of the Stress of Bereavement

Häftad, 1984

1 999 kr

New Vaccine Development

Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health

Häftad, 1986

1 929 kr

Physician Staffing for the VA

Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb

Häftad, 1991

1 257 kr

Risk Communication and Vaccination

Institute of Medicine, Board on Health Promotion and Disease Prevention, Michael A. Stoto, Barbara Loe Fisher, Richard B. Johnston, Ann Bostrom, Geoffrey Evans

Häftad, 1997

1 328 kr

Hoppa över listan

Mer från samma serie

Breakthrough Business Models

Institute of Medicine, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Robert Giffin, Sally Robinson, Theresa Wizemann

Häftad, 2009

728 kr

Challenges for the FDA

Institute of Medicine, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development

Häftad, 2007

621 kr

Sharing Clinical Research Data

Institute of Medicine, Board on Health Care Services, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, National Cancer Policy Forum, Forum on Neuroscience and Nervous System Disorders, and Translation Forum on Drug Discovery, Development, Steve Olson, Autumn Downey

Häftad, 2013

385 kr

Envisioning a Transformed Clinical Trials Enterprise for 2030

and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Carolyn Shore, Amanda Wagner Gee, Theresa Wizemann

Häftad, 2022

279 kr

Sharing Clinical Trial Data

Institute of Medicine, Board on Health Sciences Policy, Committee on Strategies for Responsible Sharing of Clinical Trial Data

Häftad, 2015

590 kr

Hoppa över listan

Du kanske också är intresserad av

Deriving Drug Discovery Value from Large-Scale Genetic Bioresources

and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Roundtable on Genomics and Precision Health, Sarah H. Beachy, Steve Olson, Amanda Wagner Gee, Siobhan Addie

Häftad, 2016

408 kr

Envisioning a Transformed Clinical Trials Enterprise for 2030

and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Carolyn Shore, Amanda Wagner Gee, Theresa Wizemann

Häftad, 2022

279 kr

Sharing Clinical Trial Data

Institute of Medicine, Board on Health Sciences Policy, Committee on Strategies for Responsible Sharing of Clinical Trial Data

Häftad, 2015

590 kr

Ovarian Cancers

and Medicine National Academies of Sciences, Engineering, Institute of Medicine, Board on Health Care Services, Committee on the State of the Science in Ovarian Cancer Research

Häftad, 2016

679 kr

Biomarker Tests for Molecularly Targeted Therapies

and Medicine National Academies of Sciences, Engineering, Institute of Medicine, Board on Health Care Services, Committee on Policy Issues in the Clinical Development and Use of Biomarkers for Molecularly Targeted Therapies, Harold L. Moses, Jonathan K. Phillips, Laurene A. Graig

Häftad, 2016

562 kr

Challenges for the FDA

Institute of Medicine, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development

Häftad, 2007

621 kr